Platelet-Rich Plasma Injections Prior to Total Shoulder Arthroplasty May be Associated with Increased Infection Risk in a Time-Dependent Manner
While platelet-rich plasma (PRP) is widely used for managing shoulder pathology, its implications when administered shortly before total shoulder arthroplasty (TSA) are unclear. This study investigates postoperative outcomes associated with PRP use within one year of TSA, with a focus on infection and revision rates.
Source: ScienceDirect
